Active implantable standards in EU OJ (Official Journal):
This article was originally published in Clinica
Executive Summary
The European Commission has published a near-comprehensive list of standards in the Official Journal of the European Union that companies can use to aid compliance with the Active Implantable Medical Devices Directive (AIMDD). These are all standards with which compliance is assumed to mean that the manufacturer has met the relevant essential requirements of the AIMDD. Many of the standards, or parts of them, published in the OJ (C153) on June 24 supersede previous standards. The OJ notes that publication of the references does not imply that the standards are available in all Community languages.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.